Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Omicsveu is a spatial biology company that provides fully automated solutions for multiplexing and spatial omics. The company's flagship platform, NanoVIP, enables end-to-end automation for various assays, including multiplex immunohistochemistry (mIHC), in situ hybridization (ISH), and fluorescence in situ hybridization (FISH). By integrating advanced hardware with high-performance reagents, Omicsveu facilitates high-throughput spatial analysis of tissue microenvironments. Their technology is designed to accelerate biomarker discovery and clinical research in oncology and other complex disease areas. The company is headquartered in Fremont, California, and serves the global life sciences and diagnostic markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Omicsveu.